These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3965477)

  • 1. The amplified expression of factors regulating myogenesis in L6 myoblasts.
    Wright WE
    J Cell Biol; 1985 Jan; 100(1):311-6. PubMed ID: 3965477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of rat myosin light-chain synthesis in heterokaryons between 5-bromodeoxyuridine-blocked rat myoblasts and differentiated chick myocytes.
    Wright WE; Aronoff J
    J Cell Biol; 1983 Jun; 96(6):1571-9. PubMed ID: 6853595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of differentiation in heterokaryons and hybrids involving differentiation-defective myoblast variants.
    Wright WE
    J Cell Biol; 1984 Feb; 98(2):436-43. PubMed ID: 6693490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of myoblast fusion after one round of DNA synthesis in 5-bromodeoxyuridine.
    Bischoff R; Holtzer H
    J Cell Biol; 1970 Jan; 44(1):134-50. PubMed ID: 4242927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-bromo-2'-deoxyuridine blocks myogenesis by extinguishing expression of MyoD1.
    Tapscott SJ; Lassar AB; Davis RL; Weintraub H
    Science; 1989 Aug; 245(4917):532-6. PubMed ID: 2547249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of the human type-1 insulin-like growth factor receptor in rat L6 myoblasts induces ligand-dependent cell proliferation and inhibition of differentiation.
    Quinn LS; Roh JS
    Exp Cell Res; 1993 Oct; 208(2):504-8. PubMed ID: 8375479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of myogenesis by somatic cell hybridization. II. Retention of myogenic competence and suppression of transformed properties in hybrids between differentiation competent and incompetent rat L6 myoblasts.
    Lawrence JB; Coleman JR
    J Cell Physiol; 1983 Jan; 114(1):99-110. PubMed ID: 6826666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type-1 insulin-like growth factor receptor overexpression produces dual effects on myoblast proliferation and differentiation.
    Quinn LS; Steinmetz B; Maas A; Ong L; Kaleko M
    J Cell Physiol; 1994 Jun; 159(3):387-98. PubMed ID: 8188756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of mouse myoblast commitment to terminal differentiation by mitogens.
    Linkhart TA; Clegg CH; Hauschka SD
    J Supramol Struct; 1980; 14(4):483-98. PubMed ID: 6454029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of myogenesis by somatic cell hybridization: III. Myogenic competence of hybrids derived from rat L6 myoblasts and mouse primary fibroblasts and myoblasts.
    Konieczny SF; Coleman JR
    Somatic Cell Genet; 1983 Jan; 9(1):25-42. PubMed ID: 6836450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of 5-bromodeoxyuridine on cell division and differentiation of preimplantation mouse embryos.
    Pollard DR; Baran MM; Bachvarova R
    J Embryol Exp Morphol; 1976 Feb; 35(1):169-78. PubMed ID: 1270977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cellular effect of 5-bromodeoxyuridine on the mammalian embryo.
    Bannigan J; Langman J
    J Embryol Exp Morphol; 1979 Apr; 50():123-35. PubMed ID: 458350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in ganglioside metabolism during in vitro differentiation of quail embryo myoblasts.
    Dubois C; Hauttecoeur B; Coulon-Morelec MJ; Montarras D; Rampini C; Fiszman MY
    Dev Biol; 1984 Oct; 105(2):509-17. PubMed ID: 6479448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a stable, posttranslationally modified microtubule array is an early event in myogenic differentiation.
    Gundersen GG; Khawaja S; Bulinski JC
    J Cell Biol; 1989 Nov; 109(5):2275-88. PubMed ID: 2681230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SV40 T antigen inhibits expression of MyoD and myogenin, up-regulates Myf-5, but does not affect early expression of desmin or alpha 7 integrin during muscle development.
    Haider SR; Wang W; Kaufman SJ
    Exp Cell Res; 1994 Feb; 210(2):278-86. PubMed ID: 7507852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone and the insulin-like growth factor system in myogenesis.
    Florini JR; Ewton DZ; Coolican SA
    Endocr Rev; 1996 Oct; 17(5):481-517. PubMed ID: 8897022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional expression of non-repetitive DNA during normal and BUdR-mediated inhibition of myogenesis in culture.
    Colbert DA; Coleman JR
    Exp Cell Res; 1977 Oct; 109(1):31-42. PubMed ID: 561698
    [No Abstract]   [Full Text] [Related]  

  • 18. Reconstitution of cells by fusion of cell fragments. I. Myogenic expression after fusion of minicells from rat myoblasts (L6) with mouse fibroblast (A9) cytoplasm.
    Ringertz NR; Krondahl U; Coleman JR
    Exp Cell Res; 1978 May; 113(2):233-46. PubMed ID: 299643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of gap junctions in cultured rat L6 cells during myogenesis.
    Balogh S; Naus CC; Merrifield PA
    Dev Biol; 1993 Feb; 155(2):351-60. PubMed ID: 8381751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metalloendoprotease inhibitors which block the differentiation of L6 myoblasts inhibit insulin degradation by the endogenous insulin-degrading enzyme.
    Kayalar C; Wong WT
    J Biol Chem; 1989 May; 264(15):8928-34. PubMed ID: 2656690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.